i-care
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80020783
- Status
- Active licence
- Licence date
- 15 July 2010
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 8 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 300 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 100 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate | 250 mcg | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 5 mg | 10,000 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 12.5 mcg | 25 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 4 mg | 8,000 µg |
| Cuivre Source : Sulfate cuivrique anhydre | 1 mg | 2,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 200 UI | 5 mcg | 10 µg |
| Vitamine A Source : Bêta carotène Potency : 2,500 UI | 750 mcg EAR | Not calculated |
| Thiamine Source : Monochlorure de thiamine | 1.13 mg | 2,260 µg |
| Manganèse Source : Sulfate de manganèse (II) | 2.5 mg | 5,000 µg |
| Vitamine C | 150 mg | 300,000 µg |
| Niacine | 17.5 mg | Not calculated |
| Phosphore Source : Phosphate de calcium, dibasique | 62.5 mg | 125,000 µg |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Fleur | 5 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta | 5 mg | Not calculated |
| Iode Source : Iodure de potassium | 75 mcg | 150 µg |
| Chrome Source : Produit de chélation de chrome et de PVH | 50 mcg | 100 µg |
| Molybdène Source : Citrate de molybdène | 12.5 mcg | 25 µg |
Non-medicinal ingredients
Croscarmellose de sodium, cellulose, D-Glucose polymer, Complexes de cuivre de chlorophylles et de chorophyllines, Poly(éthylène glycol), Maltodextrine, Talc, Huile de noix de coco, Dioxyde de titanium, Stéarate de magnésium, Zéaxanthine, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80020783
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.